Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Healthtrust
Harvard Business School
Cerilliant
Colorcon
Mallinckrodt
Cipla
Queensland Health
Cantor Fitzgerald

Generated: May 27, 2018

DrugPatentWatch Database Preview

SURITAL Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Surital patents expire, and when can generic versions of Surital launch?

Surital is a drug marketed by Parkedale and is included in one NDA.

The generic ingredient in SURITAL is thiamylal sodium. There are three drug master file entries for this compound. Additional details are available on the thiamylal sodium profile page.
Summary for SURITAL
Drug patent expirations by year for SURITAL
Medical Subject Heading (MeSH) Categories for SURITAL
Synonyms for SURITAL
337-47-3
4,6-(1H,5H)-Pyrimidinedione, dihydro-5-(1-methylbutyl)-5-(2-propenyl)-2-thioxo-, monosodium salt
4,6(1H,5H)-Pyrimidinedione, dihydro-5-(1-methylbutyl)-5-(2-propenyl)-2-thioxo-, monosodium salt
5-Allyl-5-(1-methylbutyl)-2-thio-barbituric acid sodium salt
5-Allyl-5-(1-methylbutyl)-2-thiobarbiturate sodium
5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid, sodium derivative
5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid, sodium salt
BARBITURIC ACID, 5-ALLYL-5-(1-METHYLBUTYL)-2-THIO-, SODIUM SALT
C12H17N2O2S.Na
CAS-337-47-3
CCG-213640
CHEBI:9537
CHEMBL1201065
D00713
DSSTox_CID_25988
DSSTox_GSID_45988
DSSTox_RID_81275
DTXSID3045988
EINECS 206-415-5
HMS2094G05
HMS503E21
LS-23765
NCGC00095772-01
NCGC00095772-02
SCHEMBL34746
Sodium 5-allyl-5-(1-methylbutyl)-2-thiobarbiturate
Sodium thiamylal
SPECTRUM1900002
Surital (TN)
Surital sodium
Surital sodium deriv
Surital sodium deriv.
Surital sodium salt
Thiamylal sodium
Thiamylal sodium (JP17)
Thiamylal sodium [USAN:JAN]
Thiamylal sodium salt
Thiomylal sodium
Thioseconal sodium
Tox21_111517

US Patents and Regulatory Information for SURITAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parkedale SURITAL thiamylal sodium INJECTABLE;INJECTION 007600-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Parkedale SURITAL thiamylal sodium INJECTABLE;INJECTION 007600-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Parkedale SURITAL thiamylal sodium INJECTABLE;INJECTION 007600-009 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Chinese Patent Office
Cerilliant
QuintilesIMS
Merck
US Army
Fish and Richardson
Argus Health
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.